Important Information Regarding Vyzulta

Posted in Latest News on March 16, 2018.

During the March 9, 2018 Board of Optometry meeting, the board approved for addition to Rule 64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents, Vyzulta (latanoprostene bunod ophthalmic solution) 0.024%.

Important note, Vyzulta, at this time, cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on this site, and at that time Vyzulta may be prescribed by certified optometrists.

 



More Latest News

New Legislation Impacting Your Profession
June 29, 2021

Click here to view a full list of bill summaries from the 2021 Florida Legislative Session that may impact your profession. Continue reading


Third Quarter Performance Report
June 9, 2021

Released for the
2020-21 Fiscal Year Continue reading